Cytogenetic and Genome Research
Developmental anomaly in the mouse associated with triploidyWróblewska J.Department of Embryology, Zoological Institute, University of Warsaw, Warsaw
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Accepted: July 17, 1970
Published online: April 30, 2008
Issue release date: 1971
Number of Print Pages: 9
Number of Figures: 0
Number of Tables: 0
ISSN: 1424-8581 (Print)
eISSN: 1424-859X (Online)
For additional information: https://www.karger.com/CGR
Abstract
Morphological studies of mouse embryos (F1hybrids between inbred strains of CBA females and CBA-T6T6 males) on the 9th, 10th, and 11th day of development revealed a characteristic disturbance in embryogenesis, inhibited development of the embryonic part of the egg-cylinder. This disturbance first appeared on the 9th day but did not affect the fetal membranes, which retained their normal appearance until the 11th day. All the egg-cylinders characterized by this anomaly were triploid. The presence of only one T6 marker chromosome showed that triploidy occurred as a result of digyny.
© 1971 S. Karger AG, Basel
Related Articles:
Article / Publication Details
Accepted: July 17, 1970
Published online: April 30, 2008
Issue release date: 1971
Number of Print Pages: 9
Number of Figures: 0
Number of Tables: 0
ISSN: 1424-8581 (Print)
eISSN: 1424-859X (Online)
For additional information: https://www.karger.com/CGR
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Get Permission